KIMOZO Trademark

Trademark Overview


On Friday, March 18, 2022, a trademark application was filed for KIMOZO with the United States Patent and Trademark Office. The USPTO has given the KIMOZO trademark a serial number of 79340837. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 11, 2023. This trademark is owned by ORPHELIA PHARMA. The KIMOZO trademark is filed in the Pharmaceutical Products category with the following description:

Autonomic drugs for medical use; medicines; medicines for human medicine; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations; pharmaceutical preparations for treatment of diseases affecting the peripheral nervous system; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical products for prevention of nervous system diseases; pharmaceutical products for prevention of nervous system disorders; chemotherapeutic agents; anti-cancer drugs; compounds for pharmaceutical use; cancer treatment compounds; pharmaceutical preparations and substances for cancer treatment; preparations and substances for medical use for removing tumors; Pharmaceutical substances and preparations used in oncology; pharmaceutical preparations for use in oncology; pharmaceutical preparation...
kimozo

General Information


Serial Number79340837
Word MarkKIMOZO
Filing DateFriday, March 18, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAutonomic drugs for medical use; medicines; medicines for human medicine; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations; pharmaceutical preparations for treatment of diseases affecting the peripheral nervous system; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical products for prevention of nervous system diseases; pharmaceutical products for prevention of nervous system disorders; chemotherapeutic agents; anti-cancer drugs; compounds for pharmaceutical use; cancer treatment compounds; pharmaceutical preparations and substances for cancer treatment; preparations and substances for medical use for removing tumors; Pharmaceutical substances and preparations used in oncology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameORPHELIA PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Friday, December 30, 2022ASSIGNED TO EXAMINER
Thursday, May 19, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022APPLICATION FILING RECEIPT MAILED
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Monday, September 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, December 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 27, 2023REFUSAL PROCESSED BY MPU
Monday, February 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 21, 2023REFUSAL PROCESSED BY IB
Monday, September 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, November 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, September 12, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 12, 2024FINAL DISPOSITION NOTICE SENT TO IB